title: Vaccination for asthma exacerbations.
abstract: Most asthma exacerbations are caused by common cold virus infections, predominantly rhinovirus infections. Full protection against repeat infections with the same rhinovirus serotype is given by serum neutralizing antibody, but cross-reactive antibody developed against other serotypes could yield partial protection and result in attenuated cold and airway symptoms. It is proposed that vaccine-mediated induction of cross-reactive antibody might not prevent rhinovirus infections but might reduce severe asthma symptoms and exacerbations.
authors.affiliation: Department of Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Victoria, Australia. p.bardin@southernhealth.org.au
authors.forename: P G
authors.initials: PG
authors.lastname: Bardin
mesh_terms: D001249:Asthma / Q000628:therapy*; D003429:Cross Reactions; D006801:Humans; D012229:Rhinovirus / Q000276:immunology*; D014611:Vaccination; D014765:Viral Vaccines
chemical_list: D014765:Viral Vaccines